Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             31 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) and satraplatin (OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum(IV) Sova, Petr
2010
67 6 p. 1247-1256
artikel
2 A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC Pallis, Athanasios G.
2010
67 6 p. 1239-1245
artikel
3 A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer Kanai, Masashi
2010
67 6 p. 1429-1434
artikel
4 A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan Chen, Jen-Shi
2010
67 6 p. 1281-1289
artikel
5 A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy Kato, Ken
2010
67 6 p. 1265-1272
artikel
6 A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies Fracasso, Paula M.
2010
67 6 p. 1225-1237
artikel
7 Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor Levi, Edi
2010
67 6 p. 1401-1413
artikel
8 Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models Gamez, Idoia
2010
67 6 p. 1415-1422
artikel
9 Detection of doxorubicin hydrochloride accumulation in the rat brain after morphine treatment by mass spectrometry Sardi, Iacopo
2010
67 6 p. 1333-1340
artikel
10 Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant Stoch, S. Aubrey
2010
67 6 p. 1313-1321
artikel
11 Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy Masuda, Takeshi
2011
67 6 p. 1465-1469
artikel
12 Erratum to: Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients Buonerba, Carlo
2011
67 6 p. 1463
artikel
13 Estimating the correct way of calculating the carboplatin dose Sierra-Sánchez, Jesús F.
2011
67 6 p. 1479-1480
artikel
14 Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer Takahari, D.
2010
67 6 p. 1423-1428
artikel
15 Interleukin-1 receptor antagonist attenuates cyclophosphamide-induced mucositis in a murine model Xiang, Di
2010
67 6 p. 1445-1453
artikel
16 NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer Hilli, Johanna
2010
67 6 p. 1353-1362
artikel
17 Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies Singh, Simendra
2011
67 6 p. 1211-1224
artikel
18 p53-dependent anticancer effects of leptomycin B on lung adenocarcinoma Shao, Changxia
2010
67 6 p. 1369-1380
artikel
19 Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101) Steele, N. L.
2010
67 6 p. 1273-1279
artikel
20 Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer Kang, Yoon-Koo
2010
67 6 p. 1435-1443
artikel
21 Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer Kunisaki, Chikara
2010
67 6 p. 1363-1368
artikel
22 Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis Hong, Junshik
2010
67 6 p. 1323-1331
artikel
23 Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer Lu, Yen-Shen
2010
67 6 p. 1257-1263
artikel
24 Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients Buonerba, Carlo
2011
67 6 p. 1455-1461
artikel
25 Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin Tang, Chi-Hui
2010
67 6 p. 1389-1400
artikel
26 Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model Chuk, Meredith K.
2010
67 6 p. 1291-1297
artikel
27 Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator Rausch, Linda
2010
67 6 p. 1341-1352
artikel
28 Prospectives and limitations by a novel algorithm Holweger, Karin
2011
67 6 p. 1481-1482
artikel
29 Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance Kalimutho, Murugan
2010
67 6 p. 1299-1312
artikel
30 The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients Chew, Sin-Chi
2011
67 6 p. 1471-1478
artikel
31 Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation Bugger, Heiko
2010
67 6 p. 1381-1388
artikel
                             31 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland